Beyond the cost of biologics: employer survey reveals gap in understanding role of specialty pharmacy and benefit design [0.03%]
超越生物药的成本：雇主调查揭示了对专科药房及福利设计作用的理解差距
F Randy Vogenberg,Cheryl Larson,Margaret Rehayem et al.
F Randy Vogenberg et al.
Background: Advances in biotechnology have led to the development of many new medical therapies for a variety of diseases. These agents, known as biologics or specialty drugs, represent the fastest-growing segment of phar...
Gary M Owens
Gary M Owens